Search Within

Brian Kushner

  1. "2012"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Neuroblastoma Service (7)
  2. Pediatrics, Department of (7)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (6)
  5. GSK Faculty (6)
  6. Neuro-Oncology Service (6)

More Groups

People
  1. Shakeel Modak (7)
  2. Kim Kramer (6)
  3. Nai-Kong Cheung (6)
  4. Ellen Basu (4)
  5. Stephen Roberts (3)
  6. Irene Cheung (2)

More People

Years
  1. 2012 (7)
Publications
  1. Pediatric Blood and Cancer (3)
  2. International Journal of Radiation Oncology, Biology, Physics (2)
  3. Journal of Clinical Oncology (1)
  4. Journal of Immunotherapy (1)
Publishers
  1. Wiley Periodicals, Inc (3)
  2. Elsevier Inc. (2)
  3. American Society of Clinical Oncology (1)
  4. Lippincott Williams & Wilkins (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S.; Gallagher, M.; Hsu, K.
    Journal of Immunotherapy (2012)

    Fulltext@MSK | Save
  • Stereotactic body radiation therapy for palliation in relapsed neuroblastoma
    Meeting Abstract

    Dharmarajan, K. V.; Basu, E. M.; Cheung, N. V.; Kramer, K.; Kushner, B. H.; Modak, S.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT)
    Meeting Abstract

    Kushner, B. H.; Modak, S.; Magnan, H.; Wolden, S. L.; Desai, N. B.; Alektiar, K. M.; Stein, N. F.; LaQuaglia, M. P.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma: Preliminary results
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Gallagher, M.; Hsu, K.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte- macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission
    Journal Article

    Cheung, N. K. V.; Cheung, I. Y.; Kushner, B. H.; Ostrovnaya, I.; Chamberlain, E.; Kramer, K.; Modak, S.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma
    Journal Article

    Modak, S.; Cheung, I. Y.; Kushner, B. H.; Kramer, K.; Reich, L.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save